These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19041355)

  • 21. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
    Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
    J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of antibodies to non-structural proteins of foot-and-mouth disease virus in repeatedly vaccinated cattle.
    Lee F; Jong MH; Yang DW
    Vet Microbiol; 2006 Jun; 115(1-3):14-20. PubMed ID: 16446061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indirect foot-and-mouth disease vaccine potency testing based on a serological alternative.
    Goris N; Willems T; Diev VI; Merkelbach-Peters P; Vanbinst T; Van der Stede Y; Kraft HP; Zakharov VM; Borisov VV; Nauwynck HJ; Haas B; De Clercq K
    Vaccine; 2008 Jul; 26(31):3870-9. PubMed ID: 18555565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic and antigenic analysis of type A foot-and-mouth disease viruses isolated in India during 1987-1996.
    Nayak B; Pattnaik B; Tosh C; Sanyal A; Hemadri D; Patil SS; Venkataramanan R
    Acta Virol; 2001 Feb; 45(1):13-21. PubMed ID: 11394573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of seroreagents to FMDV in the cattle population in Poland: results of 9-year monitoring studies.
    Niedbalski W
    Pol J Vet Sci; 2003; 6(1):1-5. PubMed ID: 12675463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage.
    Waters R; Ludi AB; Fowler VL; Wilsden G; Browning C; Gubbins S; Statham B; Bin-Tarif A; Mioulet V; King DJ; Colenutt C; Brown E; Hudelet P; King DP
    Vaccine; 2018 Mar; 36(14):1901-1907. PubMed ID: 29506922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquid-phase blocking sandwich enzyme-linked immunosorbent assay for detection of antibodies against foot-and-mouth disease virus in water buffalo sera.
    Araújo JP; Montassier HJ; Pinto AA
    Am J Vet Res; 1996 Jun; 57(6):840-3. PubMed ID: 8725810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foot-and-mouth disease vaccine potency testing: the influence of serotype, type of adjuvant, valency, fractionation method, and virus culture on the dose-response curve in cattle.
    Jamal SM; Bouma A; van den Broek J; Stegeman A; Chénard G; Dekker A
    Vaccine; 2008 Nov; 26(50):6317-21. PubMed ID: 18822336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse model as an efficacy test for foot-and-mouth disease vaccines.
    Gnazzo V; Quattrocchi V; Soria I; Pereyra E; Langellotti C; Pedemonte A; Lopez V; Marangunich L; Zamorano P
    Transbound Emerg Dis; 2020 Nov; 67(6):2507-2520. PubMed ID: 32320534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of serology-based vaccine potency models for foot-and-mouth disease virus.
    Willems T; Lefebvre DJ; Goris N; Diev VI; Kremenchugskaya SR; Paul G; Haas B; De Clercq K
    Vaccine; 2012 Aug; 30(40):5849-55. PubMed ID: 22824343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
    Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality assurance/quality control of foot and mouth disease solid phase competition enzyme-linked immunosorbent assay--Part I. Quality assurance: development of secondary and working standards.
    Goris N; De Clercq K
    Rev Sci Tech; 2005 Dec; 24(3):995-1004. PubMed ID: 16642770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of foot-and-mouth disease virus infection in vaccinated cattle.
    Niedbalski W
    Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
    Yao Q; Qian P; Huang Q; Cao Y; Chen H
    J Virol Methods; 2008 Jan; 147(1):143-50. PubMed ID: 17963851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
    Fowler VL; Paton DJ; Rieder E; Barnett PV
    Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FMD virus isolates: the candidate strains for polyvalent vaccine development in Ethiopia.
    Ayelet G; Soressa M; Sisay T; Belay A; Gelaye E; Jembere S; Skjerve E; Asmare K
    Acta Trop; 2013 Jun; 126(3):244-8. PubMed ID: 23416124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A recombinant protein-based ELISA for detecting antibodies to foot-and-mouth disease virus serotype Asia 1.
    Ko YJ; Jeoung HY; Lee HS; Chang BS; Hong SM; Heo EJ; Lee KN; Joo HD; Kim SM; Park JH; Kweon CH
    J Virol Methods; 2009 Jul; 159(1):112-8. PubMed ID: 19442854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune responses of pigs to commercialized emulsion FMD vaccines and live virus challenge.
    Chen SP; Lee MC; Sun YF; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR; Ellis TM
    Vaccine; 2007 May; 25(22):4464-9. PubMed ID: 17445957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foot and mouth disease vaccine strain selection: current approaches and future perspectives.
    Mahapatra M; Parida S
    Expert Rev Vaccines; 2018 Jul; 17(7):577-591. PubMed ID: 29950121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.